Friday, July 10, 2026

pharma · Rheumatoid Arthritis

Dr. Reddy's Laboratories

Dr Reddy''s Laboratories is a pharma organization headquartered in AU. Primary therapeutic focus areas include Rheumatoid Arthritis. NovaPharmaNews links 1 clinical program(s), 2 drug profile(s), and 0 patent record(s) t

Princeton, USA HQ
6 Employees
TGA registrant Type
Company details
Status
Public
HQ
Princeton, USA
Employees
6
Programs
1
Drugs
7
Patents
0
Clinical program

AB-01-004

Phase 3 · small molecule · Rheumatoid Arthritis

AB-01-004 for Rheumatoid Arthritis is a Phase 3 program (small_molecule) at Dr Reddy''s Laboratories (Australia) Pty Ltd with 1 ClinicalTrials.gov record(s).

Internal code AB-01-004

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Dr Reddy''s Laboratories (Australia) Pty Ltd
Phase
Phase 3
Modality
small_molecule
Indication
Rheumatoid Arthritis
Status
active
Trials
1